Social costs of smoking in the Czech Republic

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11230%2F25%3A10485873" target="_blank" >RIV/00216208:11230/25:10485873 - isvavai.cz</a>

Výsledek na webu

<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=ftUd__fijU" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=ftUd__fijU</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1007/s40258-024-00917-w" target="_blank" >10.1007/s40258-024-00917-w</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Social costs of smoking in the Czech Republic

Popis výsledku v původním jazyce

The article estimates the social costs of smoking in the Czech Republic using the prevalence-based, cost-of-illness approach. This approach assesses the costs as the sum of direct (healthcare) costs and indirect costs (productivity losses due to mortality and morbidity). The costs of healthcare utilization and pharmacotherapy in direct costs, and the costs of absenteeism, presenteeism, and premature mortality in indirect costs, are included. The costs are estimated as 2110.6 million EUR (0.94% of GDP) in 2019. Despite the declining prevalence of smoking in the Czech Republic, the social costs are considerable and investments into strategies to reduce smoking continue to be needed.

Název v anglickém jazyce

Social costs of smoking in the Czech Republic

Popis výsledku anglicky

The article estimates the social costs of smoking in the Czech Republic using the prevalence-based, cost-of-illness approach. This approach assesses the costs as the sum of direct (healthcare) costs and indirect costs (productivity losses due to mortality and morbidity). The costs of healthcare utilization and pharmacotherapy in direct costs, and the costs of absenteeism, presenteeism, and premature mortality in indirect costs, are included. The costs are estimated as 2110.6 million EUR (0.94% of GDP) in 2019. Despite the declining prevalence of smoking in the Czech Republic, the social costs are considerable and investments into strategies to reduce smoking continue to be needed.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

50201 - Economic Theory

Projekt

—

Návaznosti

S - Specificky vyzkum na vysokych skolach<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2025

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Applied Health Economics and Health Policy

ISSN

1175-5652

e-ISSN

1179-1896

Svazek periodika

23

Číslo periodika v rámci svazku

January 2025

Stát vydavatele periodika

NZ - Nový Zéland

Počet stran výsledku

13

Strana od-do

141-153

Kód UT WoS článku

001321459000001

EID výsledku v databázi Scopus

2-s2.0-85205239793